標題: Titlebook: Beyond Becquerel and Biology to Precision Radiomolecular Oncology: Festschrift in Honor of Richard P; Vikas Prasad Book‘‘‘‘‘‘‘‘ 2024 The E [打印本頁] 作者: TUMOR 時間: 2025-3-21 17:10
書目名稱Beyond Becquerel and Biology to Precision Radiomolecular Oncology: Festschrift in Honor of Richard P影響因子(影響力)
書目名稱Beyond Becquerel and Biology to Precision Radiomolecular Oncology: Festschrift in Honor of Richard P影響因子(影響力)學(xué)科排名
書目名稱Beyond Becquerel and Biology to Precision Radiomolecular Oncology: Festschrift in Honor of Richard P網(wǎng)絡(luò)公開度
書目名稱Beyond Becquerel and Biology to Precision Radiomolecular Oncology: Festschrift in Honor of Richard P網(wǎng)絡(luò)公開度學(xué)科排名
書目名稱Beyond Becquerel and Biology to Precision Radiomolecular Oncology: Festschrift in Honor of Richard P被引頻次
書目名稱Beyond Becquerel and Biology to Precision Radiomolecular Oncology: Festschrift in Honor of Richard P被引頻次學(xué)科排名
書目名稱Beyond Becquerel and Biology to Precision Radiomolecular Oncology: Festschrift in Honor of Richard P年度引用
書目名稱Beyond Becquerel and Biology to Precision Radiomolecular Oncology: Festschrift in Honor of Richard P年度引用學(xué)科排名
書目名稱Beyond Becquerel and Biology to Precision Radiomolecular Oncology: Festschrift in Honor of Richard P讀者反饋
書目名稱Beyond Becquerel and Biology to Precision Radiomolecular Oncology: Festschrift in Honor of Richard P讀者反饋學(xué)科排名
作者: 凌辱 時間: 2025-3-21 21:11 作者: 放氣 時間: 2025-3-22 01:06 作者: cauda-equina 時間: 2025-3-22 06:05 作者: magenta 時間: 2025-3-22 09:40
Conference proceedings‘‘‘‘‘‘‘‘ 2018 FDG PET/CT..Results: When using FDG PET/CT for response assessment, following important items should be considered: (1) . meaning that we can see transient enlargement of tumors or the appearance of new tumors followed by tumor shrinkage or long-term stability of tumor size. (2) . which is characte作者: Connotation 時間: 2025-3-22 14:30 作者: 斗志 時間: 2025-3-22 18:33 作者: Moderate 時間: 2025-3-23 00:27
International Political Economy Seriessue responses as a function of the calculated radiation dose. This includes radiotoxicities of normal, healthy organs which cause an upper limit of the administered activity and are controlled very well. In the case of the kidney the toxicity by Radionuclide Therapy was successfully described via ra作者: diabetes 時間: 2025-3-23 05:26
https://doi.org/10.1057/9781137489593T) of neuroendocrine tumors (NETs), which are the prediction of efficacy and toxicity and the consequent patient stratification. In the following years, we conducted clinical trials to understand the role of individual predisposition and specific tumor genomic profile in the response and toxicity to作者: 治愈 時間: 2025-3-23 07:27 作者: 討厭 時間: 2025-3-23 10:00
International Corporate Brand Managementasing, particularly in low-risk differentiated thyroid cancer. Several tracers were developed to visualize iodine-negative tissue for PET as well as for SPECT imaging for therapy planning and response assessment. Substances like dabrafenib proved to be able to reinduce radioiodine uptake in some pat作者: 全部 時間: 2025-3-23 17:20 作者: 猛擊 時間: 2025-3-23 18:17 作者: MAL 時間: 2025-3-24 00:21 作者: 嘲笑 時間: 2025-3-24 05:42 作者: 夜晚 時間: 2025-3-24 08:22
From Concept to Clinic and Commercialization: Cowboys Wanted,hat time, through varying degrees of economic prosperity, I have received a great deal of candid feedback about how investors view the nuclear medicine industry. These perceptions offer provocative insights into our industry and I believe they are worth sharing, both for information and entertainmen作者: mortgage 時間: 2025-3-24 14:40
From Radiochemistry of the Lanthanides to 225Ac and the Interference with Richard Baum,others), he is promoting those close collaboration and has created a network around the world independent on political and economic situation in countries like Cuba, China, South Africa, and others. His strong engagement is motivating us in developing new techniques making new radionuclides availabl作者: 甜食 時間: 2025-3-24 18:31
,“How Do You Feel About Dosimetry?” The Gretchenfrage of Radionuclide Therapy,sue responses as a function of the calculated radiation dose. This includes radiotoxicities of normal, healthy organs which cause an upper limit of the administered activity and are controlled very well. In the case of the kidney the toxicity by Radionuclide Therapy was successfully described via ra作者: 幼稚 時間: 2025-3-24 21:56
The LuGenIum Triptych: Ode to a Theranostic Transcriptome,T) of neuroendocrine tumors (NETs), which are the prediction of efficacy and toxicity and the consequent patient stratification. In the following years, we conducted clinical trials to understand the role of individual predisposition and specific tumor genomic profile in the response and toxicity to作者: parasite 時間: 2025-3-25 03:08 作者: hieroglyphic 時間: 2025-3-25 04:39 作者: 牲畜欄 時間: 2025-3-25 07:31 作者: TATE 時間: 2025-3-25 13:57 作者: blister 時間: 2025-3-25 17:47 作者: Spinal-Tap 時間: 2025-3-25 21:49
Fighting for PET in German Oncological Guidelines and for Its Reimbursement by Statutory Health Insmportant indications despite its recommendation in international guidelines. This chapter describes the long way of PET and PET/CT into German guidelines and reimbursement for the example of lung cancer, to which the jubilarian made crucial contributions.作者: 主動脈 時間: 2025-3-26 04:08 作者: 進取心 時間: 2025-3-26 07:17 作者: gratify 時間: 2025-3-26 10:47 作者: 眨眼 時間: 2025-3-26 16:04
Book‘‘‘‘‘‘‘‘ 2024of Richard P Baum..It includes commentaries, reviews and some thought provoking novel ideas on radionuclide precision oncology, covering topics such as various aspects of theranostics and molecular radiotherapy like radiolabeled peptides, radiolabeled antibodies, dosimetry, and quality control as we作者: NEXUS 時間: 2025-3-26 19:16
https://doi.org/10.1007/978-94-009-0793-5 that in the next 25 years the majority of new NCD cases and associated deaths will occur in LMICs. The increase in NCDs is related to several factors, including population growth, increased life expectancy and changes in lifestyle. The most frequent NCDs are cardiovascular diseases, cancer, chronic respiratory diseases and diabetes.作者: RALES 時間: 2025-3-27 00:36
https://doi.org/10.1007/978-3-658-00406-4mportant indications despite its recommendation in international guidelines. This chapter describes the long way of PET and PET/CT into German guidelines and reimbursement for the example of lung cancer, to which the jubilarian made crucial contributions.作者: 沉積物 時間: 2025-3-27 05:12
Understandings of Law in Croatia,n the contrary, in spite of his own scepticism, intelligent multidisciplinary targeted nanoparticles could be constructed although being cumbersome. Here radiotheragnostic compounds will play major role. Additionally, some personal aspects are presented in order to honour Richard Baum’s achievements.作者: 一夫一妻制 時間: 2025-3-27 07:34
State Immunity: A Swedish Perspectivegraphy, PET/CT) has a reduced sensitivity with lower tumor size. Sufficient, preoperative, and intraoperative imaging can provide the surgeon with valuable assistance and also significantly simplify the surgical procedure. Depending on the intraoperative findings, the surgical intervention can be expanded or even significantly reduced.作者: AFFIX 時間: 2025-3-27 12:28 作者: 委托 時間: 2025-3-27 14:02
https://doi.org/10.1007/978-3-658-00406-4 an increasing demand for high-quality radionuclides and radiopharmaceuticals has triggered the expansion of nuclear medicine as a hospital speciality, together with the development of a new radiotheranostics industry.作者: Pantry 時間: 2025-3-27 20:48 作者: Cultivate 時間: 2025-3-27 22:28
The Evolution of n.c.a. 177Lu to n.c.a. 177Lu-Edotreotide for the Treatment of Neuroendocrine Tumou an increasing demand for high-quality radionuclides and radiopharmaceuticals has triggered the expansion of nuclear medicine as a hospital speciality, together with the development of a new radiotheranostics industry.作者: 加劇 時間: 2025-3-28 02:36
The Role of Individuals for Innovation: The Nuclear Medicine Biotope,ne in 1941, the basic methodologies of nuclide generation, radiochemistry, imaging physics, engineering and biomedical data analysis all had to be developed de novo. This article intends to synoptically highlight individual key contributions enabling current molecular imaging and radiotherapy.作者: 愛哭 時間: 2025-3-28 06:53
https://doi.org/10.1057/9781137489593of surgery and peptide receptor radionuclide therapy (PPRT). Here, the authors review the challenges posed by advanced NEN, review the fledgling evidence regarding the combination of PRRT and surgery, and present the case for a wider examination of embedding PRRT and surgery within a multimodal treatment strategy.作者: 臥虎藏龍 時間: 2025-3-28 12:42 作者: hankering 時間: 2025-3-28 15:06 作者: ingrate 時間: 2025-3-28 19:07
PSMA Radioligand Therapy: A Revolution in the Precision Radiomolecular Oncology of Prostate Cancer, as well as the newer generation apalutamide and darolutamide. However, these treatment regimens only provide a meager survival benefit in mCRPC. Radium-223 targets only the osteoblastic metastases and does not treat nodal or visceral metastases. Therefore, there has been an unmet need for targeted therapy.作者: Hypomania 時間: 2025-3-29 00:33 作者: Fulsome 時間: 2025-3-29 03:10 作者: eucalyptus 時間: 2025-3-29 08:55 作者: 投票 時間: 2025-3-29 15:17
Conference proceedings‘‘‘‘‘‘‘‘ 2018ncer cells, on the basis of the concept of immune surveillance by activating both cell-mediated and humoral immunity to fight cancer. Immunomodulatory monoclonal antibody therapy utilizes preformed monoclonal antibodies directed against molecular targets to regulate T-cell activation. There are thre作者: 證實 時間: 2025-3-29 16:23 作者: Texture 時間: 2025-3-29 21:30 作者: 泥瓦匠 時間: 2025-3-30 02:08
International Political Economy Serieseated PET centers have significant success and others do not have at all. His answer was simple and clear: institutions where physicians accept scientists, for instance radio-chemists and physicists as equal partners and where they collaborate truly together, there the progress is programmed. In my 作者: colony 時間: 2025-3-30 04:58 作者: 小教堂 時間: 2025-3-30 11:41 作者: 專心 時間: 2025-3-30 15:48 作者: 山間窄路 時間: 2025-3-30 20:13
https://doi.org/10.1007/978-94-009-0793-5poor prognosis with a median overall survival time of only 9–15 months. The infiltrating nature of the tumour cells, inter- and intra-tumoral molecular heterogeneity and the tumour’s propensity to hide behind the blood-brain barrier are the key causes of the insufficiency of the optimal available tr作者: 悠然 時間: 2025-3-30 21:51 作者: anaerobic 時間: 2025-3-31 01:35
International Corporate Brand Managementand survival. Targeted cancer therapeutics are amongst the major treatment options for cancer today. These treatments are more selective for cancer cells and improve the quality of life for cancer patients undergoing therapy. Nevertheless, cardiotoxicity is a frequent side effect in targeted therapi作者: 最高峰 時間: 2025-3-31 05:36 作者: 未成熟 時間: 2025-3-31 09:41
https://doi.org/10.1007/978-3-658-00406-4heir scientific basis, further aspects are important for new medical procedures to be introduced into broad clinical care. In this matter, we in Germany have special experiences with PET which is still not fully recognized by statutory health insurances as the standard procedure of choice for many i作者: Obverse 時間: 2025-3-31 14:44
International Courts and Mass Atrocity(theranostics) of prostate cancer, particularly in the metastatic castrate-resistant state. Numerous investigations from around the world in both academic and pharma settings are focused on research and development of safe and effective PSMA-based theranostic agents. Encouraging results from retrosp作者: 扔掉掐死你 時間: 2025-3-31 19:42
Understandings of Law in Croatia, 1980s and ended up with radiomolecular precision oncology in 2020s. The author also had own interests which Richard Baum did not touch. The author worked some time with oligonucleotide radionuclide therapy (radionanotargeting) in the 1990s learning that it will be impossible in clinical practice. O
